-
-
-
-
-
-
- Code of Professional Conduct for Veterinary Surgeons
- Code of Professional Conduct for Veterinary Nurses
- Contact the Advice Team
- XL Bully dog ban
- 'Under care' - new guidance
- Advice on Schedule 3
- Controlled Drugs Guidance – A to Z
- Dealing with Difficult Situations webinar recordings
- FAQs – Common medicines pitfalls
- FAQs – Routine veterinary practice and clinical veterinary research
- GDPR – RCVS information and Q&As
Prof Lloyd Reeve-Johnson
BVM&S CBiol FIBiol PhD MBBS DVM&S DipECVPT
FRCVS
![Lloyd Reeve-Johnson Lloyd Reeve-Johnson](https://d25vlx267nhz7w.cloudfront.net/6006266.png)
- Location: Australia
- Year of Fellowship: 2002
- Route to Fellowship: By thesis
Field of work
Universities and colleges
Areas of special interest
- One Health
- Health economics
- Pharmacology and Epidemiology
Areas of support
- International issues
- One Health Agenda
- Public engagement
Professional positions
- Professor of One Health
- European Union Recognised Specialist in Veterinary Pharmacology
- President European Association of Veterinary Pharmacology and Toxicology
- Distinguished Fellow of Royal Academy of Veterinary Sciences, Spain
- Fellow of Royal College of Veterinary Surgeons, UK
- Fellow of the Royal Australian College of General Practitioners
- Chair, Australasian branches of the Royal Society of Biology
- Chair, School Board, Our Lady of Rosary School
Awards
- Thomas Hughes Award
- Iams travel scholar
- Parry Exhibitionary Award
- Avant DIT scholar
- Plenary and Keynote Speaker internationally
Biography
Lloyd Reeve-Johnson is Professor of One Heath at the University of Sunshine Coast in Australia. He is also Adjunct Professor at the Institute of Health and Biomedical Innovation at the Queensland University of Technology and until recently was a Principal Research Fellow at the flagship Translational Research Institute in Brisbane.
He is a former Dean of the Queensland Veterinary College and Director of European Union Research and Development with Elanco Animal Health.
He is a Diplomate of the European College of Veterinary Pharmacology and Toxicology, President of the European Association of Veterinary Pharmacology and Toxicology and President of the Australasian Society of Biology.
He was previously an owner of one of the larger veterinary groups in the UK and keeps up clinical practice as both a veterinarian and medical doctor.
He is passionate about One Health and disease management, having over his career worked in over 100 countries on projects related to human and animal health & has project managed the registration of over 60 veterinary products internationally with FDA, EMEA, NZFSA, APVMA and other registration agencies. His research has involved human and animal disease solutions including sentinel developments in macrolide antibiotic therapies. His current interests focus particularly where translational approaches are relevant to man, animals & environment, including antimicrobial resistance modelling and health economics.
He is a former Dean of the Queensland Veterinary College and Director of European Union Research and Development with Elanco Animal Health.
He is a Diplomate of the European College of Veterinary Pharmacology and Toxicology, President of the European Association of Veterinary Pharmacology and Toxicology and President of the Australasian Society of Biology.
He was previously an owner of one of the larger veterinary groups in the UK and keeps up clinical practice as both a veterinarian and medical doctor.
He is passionate about One Health and disease management, having over his career worked in over 100 countries on projects related to human and animal health & has project managed the registration of over 60 veterinary products internationally with FDA, EMEA, NZFSA, APVMA and other registration agencies. His research has involved human and animal disease solutions including sentinel developments in macrolide antibiotic therapies. His current interests focus particularly where translational approaches are relevant to man, animals & environment, including antimicrobial resistance modelling and health economics.